Trius raises $45.2M in follow-on

Trius Therapeutics Inc. (NASDAQ:TSRX) raised $45.2 million through the sale of 8.6 million shares at $5.25 in a follow-on underwritten by Citi; Piper Jaffray; Canaccord; and Ladenburg Thalmann. Trius ...